C21 Investments Inc. (CSE:CXXI)

Market Cap	52.50M
Revenue (ttm)	46.02M
Net Income (ttm)	-4.12M
Shares Out	117.97M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,535
Average Volume	43,829
Open	0.4450
Previous Close	0.4600
Day's Range	0.3900 - 0.4450
52-Week Range	0.1500 - 0.6800
Beta	2.15
RSI	51.54
Earnings Date	Nov 14, 2025

About C21 Investments

C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. The company offers CO2, live resin, distillate, CBD cured resin, and CBD CO2 vaporizer pens; live, cured, and CBD cured resin extracts; bulk and packaged flowers; edibles; pre-rolls; tinctures; and topicals. It also provides payroll and benefits services. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017. C21 ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 138
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: CXXI

Financial Performance

In 2024, C21 Investments's revenue was $30.12 million, an increase of 12.42% compared to the previous year's $26.79 million. Losses were -$3.97 million, 789.2% more than in 2023.

Financial numbers in USD